NIPT (Non-Invasive Prenatal Screening)
Safe and Early Prenatal Screening
PGT & Carrier Screening
Preconception Genetic Assessment
Molecular Genetics & NGS
High-Tech DNA Sequencing & Bioinformatics
Cancer Genetics & Oncology
Hereditary Cancer Risks & Oncology Panels
General Clinical Services
Clinical Follow-up, Counseling & Solutions
Cytogenetics & Karyotyping
Chromosome Analysis & Cytogenetic Solutions
Screening for common chromosomal abnormalities, including trisomies 21, 18 and 13, from maternal blood starting at 10 weeks.
General Genetic Tests
Onco-Hematology Panels
Corporate Profile
Ecegen Values, History & Admin Structure
Our Team & Careers
Expert Physicians and Career Opportunities
Quality & Support
ISO 15189 Standards & Frequently Asked Questions
Our corporate structure, mission, vision and values as Turkey's leading genetic diagnostics center.
Physician & Request Forms
Clinical Test Request & Analysis Documents
Patient Consent & Consultation Forms
Legal Consent, Counseling & Consultation
Digital and printable request forms for physicians ordering genetic analysis, NGS panels, or NIPT.
Press & Media
TV Broadcasts, Interviews & Scientific Conversations
News & Announcements
Latest Developments from ECEGEN
Scientific Blog
Genetic Science & Clinical Education Articles
A selection of ECEGEN television broadcasts, expert interviews, and scientific conversations.
Latest from ECEGEN
Latest announcements, events, scientific blog articles, press coverage, and accreditation updates from our laboratory.
Total 21 items listed
Serving as the gold standard for detecting chromosomal anomalies and structural rearrangements, our conventional and molecular cytogenetics workflows operate under rigorous international quality standards in sterile cleanrooms.
At the awareness programme in Bahçelievler, Prof. Dr. Zeynep Ocak discussed the importance of genetic evaluation and early detection in breast cancer.
At the symposium organized jointly by Biruni University and the ALS MNH Association, Prof. Dr. Zeynep Ocak highlighted the significance of genetic factors, early diagnosis, and biomarkers in personalized ALS treatments.
Medical Genetics Specialist Prof. Dr. Zeynep Ocak highlighted the decisive power of comprehensive genetic analyses in disease prevention, early diagnosis, and personalized therapy.
Prof. Dr. Zeynep Ocak was awarded the Science Honor Award by the Azerbaijan Ministry of Defense and the TÜBİTAK Science Board due to joint scientific projects and studies of the two countries.
At the Turkey Prestige Awards 2024, ECEGEN was awarded the “Most Successful Center of the Year” with its Artificial Intelligence Studies in Cancer Genetics.
As of 01.11.2024, ECEGEN has been accredited according to TS EN ISO 15189:2023 standard, registering its leadership in patient safety, accuracy, and quality.
Prof. Dr. Zeynep Ocak was honored with the Honorary Professorship Diploma by the VEKTOR International Science Center at the ceremony held in Baku on August 19, 2022.
A guide to FMF and recurrent fever and pain: the role of MEFV, the limitations of genetic testing, inheritance and regular follow-up.
A personalized mRNA vaccine produced long-lasting immune responses against pancreatic cancer in an early clinical study. Although encouraging, the approach remains experimental.
GLP-1 medicines can influence appetite and blood sugar regulation, but they are not suitable for everyone. We explain their effects, limitations, and why medical supervision matters.
A personalized gene-editing therapy was developed in about six months for a baby with a rare metabolic disease. Here is what this first case shows—and why it remains experimental.
The first FDA-cleared blood test for evaluating Alzheimer's disease may simplify part of the diagnostic pathway. It is not intended for screening or for making a diagnosis on its own.
An experimental gene therapy produced hearing gains in children with profound hearing loss caused by two disease-causing OTOF variants. The approach is promising but applies only to a specific genetic subtype.
Despite their massive size and long lifespans, elephants have much lower cancer rates than humans. In this article, we examine the role of the TP53 gene, known as the guardian of the genome, and Peto's Paradox.
Prof. Dr. Zeynep Ocak discusses the role of genetic testing in disease diagnosis and personalized healthcare approaches.
Prof. Dr. Zeynep Ocak talks about genetics and health on the program Yaşama Dair on EKOTÜRK TV.
Prof. Dr. Zeynep Ocak on the effects of weight-control medications on genetic metabolism and personalized medicine.
Prof. Dr. Zeynep Ocak explains the importance of early diagnosis in cancer and the role of genetic evaluation in healthcare processes.
Prof. Dr. Zeynep Ocak discusses the relationship between scoliosis and genetic factors and the clinical evaluation process.
Prof. Dr. Zeynep Ocak explains what our genes reveal about our health and personal risks.